References
- Maury C P. J. Serum amyloid A protein-current status. Scand J Rheum 1984; 13: 91
- Sipe J D., Vogel S N., Sztein M B., Skinner M, Cohen A S. The role of interleukin I in acute-phase serum amyloid A (SAA) and serum amyloid P (SAP) biosynthesis. Ann NY Acad Sci 1982; 38: 137
- McAdam K P. W. J., Li J, Knowles J, Foss N T., Dinarello C A., Rosenwasser L J., Selinger M J., Kaplan M M., Goodman R. The biology of SAA: Identification of the inducer, in vitro synthesis, and heterogeneity demonstrated with monoclonal antibodies. Ann NY Acad Sci 1982; 389: 126
- Sztein M B., Luger T A., Oppenheim J J. An epidermal cell-derived cytokine triggers the in vivo synthesis of serum amyloid A by hepatocytes. J Immunol 1982; 129: 87
- Benditt E P., Eriksen N. Amyloid protein SAA is associated with high density lipoprotein from human serum. Proc Natl Acad Sci USA 1977; 74: 4025
- Bausserman L L., Herbert P N., McAdam K P. W. J. Heterogeneity of human serum amyloid A proteins. J Exp Med 1980; 152: 641
- Eriksen N, Benditt E P. Isolation and characterization of the amyloid related apoprotein (SAA) from human high density lipoprotein. Proc Natl Acad Sci USA 1980; 77: 6860
- Marhaug G, Sletten K, Husby G. Characterization of amyloid related protein SAA complexed with serum lipoproteins (apo SAA). Clin Exp Immunol 1982; 50: 382
- Hoffman J S., Benditt E P. Plasma clearance kinetics of the amyloid-related high density lipoprotein apoprotein, serum amyloid protein (apo SAA), in the mouse. Evidence for rapid apoSAA clearance. J Clin Invest 1983; 71: 926
- Reisfeld R A., Small P A., Jr. Electrophoretic heterogeneity of polypeptide chains of specific antibodies. Science 1966; 152: 1253
- Clamp J R. Analysis of glycoproteins. Biochem Soc Symp 1974; 40: 3
- Maury C P. J., Teppo A M., Eklund B, Ahonen J. Serum amyloid A protein: A sensitive indicator of renal allograft rejection in humans. Transplantation 1983; 36: 501
- Maury C P. J., Teppo A M., Salaspuro M P. Amyloid A fibril degrading activity in serum in liver disease—relation to serum acute phase and other protein levels. Clin Chim Acta 1983; 131: 29
- Huttunen J K., Lansimies E, Voutilainen E, Ehnholm C, Hietanen E, Penttila I, Siitonen O, Rauramaa R. Effect of moderate physical exercise on serum lipoproteins. A controlled clinical trial with special reference to serum high-density lipoproteins. Circulation 1979; 60: 1220
- Bausserman L L., Herbert P N., McAdam K P. W. J. Serum amyloid A polymorphism in a subject with a naturally occurring inflammatory response. Clin Chim Acta 1982; 118: 201
- Bausserman L L., Saritelli A L., Herbert P N., McAdam K P. W. J. NH2-terminal analysis of four of the polymorphic forms of human serum amyloid A proteins. Biochim Biophys Acta 1982; 704: 556
- Malmendier C L., Paroutaud P, Ameryckx J. Partial amino acid sequence of three new apolipoproteins isolated from high density lipoproteins. FEBS Letters 1980; 109: 43
- Hoffman J S., Ericsson L H., Eriksen N, Walsh K A., Benditt E P. Murine tissue amyloid protein AA. NH2-terminal sequence identity with only one of two serum amyloid protein (apo SAA) gene products. J Exp Med 1984; 159: 641
- Rosenthal C J., Sullivan L. Serum amyloid A. Evidence for its origin in polymorphonuclear leukocytes. J Clin Invest 1978; 62: 1181–86
- Linder E, Anders R F., Natvig J B. Connective tissue origin of the amyloid-related protein SAA. J Exp Med 1976; 144: 1336–46
- Franklin E C. Some properties of antisera to serum amyloid A protein (SAA): inhibition of precipitation by complexing of SAA to albumin. J Exp Med 1976; 144: 1679
- Hoffman J S., Benditt E P. Secretion of serum amyloid protein and assembly of serum amyloid-rich high density lipoprotein in primary mouse hepatocyte culture. J Biol Chem 1982; 257: 10518
- Hoffman J S., Benditt E P. Changes in high density lipoprotein content following endotoxin administration in the mouse. J Biol Chem 1982; 257: 10510
- Eisenberg S, Windmueller H G., Levy R I. Metabolic fate of rat and human lipoprotein apoproteins in the rat. J Lipid Res 1973; 14: 446